Drug firms pour $40 million into healthcare debate
Hear how Big Pharma spent $40 million just in April, May and June of this year to influence Congress against single-payer plans and to ensure that pharmaceutical companies will come out on top in whatever healthcare plan results. This report will tell you why you don’t find discussion of certain issues during the healthcare debate.
Andrea Seabrook and Peter Overby explain that one of the most powerful players in health care is a group called the Pharmaceutical Research and Manufacturers of America, or PhRMA. It represents just 32 brand-name drug companies, but it has so much influence that when Congress passes a bill, PhRMA almost always gets its way. One big reason why: PhRMA and its members have spent millions of dollars lobbying Congress as lawmakers work to overhaul health care.
You can read their story here, or click here to listen to All Things Considered, July 23, 2009 while you browse our site.
Also—don’t miss our views and four videos on the healthcare reform debate.
You might also like:
- Tylenol, Motrin, St. Joseph's aspirin recalled
- Bill Moyers interviews Wendell Potter, CIGNA executive
- First U.S. citizen dies from swine flu
- What does single-payer mean?
- A health care reality check from Earl Blumenauer
The Big Picture (beyond our site):
- Depression Risk Factors for Women
- Insider’s Look at Drug & Vitamin Expiration Dates
- Weakonomics Take On The Health Care Debate
- Doctors Opting Out of Medicare
- Best Reads of the Week: the Inconvenient Truth of the Health Care Debate Edition
You can leave a comment here, or a trackback from your own site.
